{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:19:04Z","timestamp":1791019144880,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.critrevonc.2009.10.007","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T04:45:40Z","timestamp":1263962740000},"page":"2-14","source":"Crossref","is-referenced-by-count":42,"title":["Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies"],"prefix":"10.1016","volume":"75","author":[{"given":"Ilaria","family":"Sogno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ven\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Imperatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2009.10.007_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib3","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-09-0095","article-title":"Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy","volume":"15","author":"Ebos","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jnci\/dji149","article-title":"Rescuing COX-2 inhibitors from the waste bin","volume":"97","author":"Albini","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib5","unstructured":"Albini A, Pennesi G, Donatelli F, Cammarota R, Flora SD, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and Cardio-Oncological Prevention, J Natl Cancer Inst; in press."},{"key":"10.1016\/j.critrevonc.2009.10.007_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.15.6331","article-title":"Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma","author":"Schmidinger","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumour microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1096\/fj.01-0300rev","article-title":"Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents","volume":"16","author":"Tosetti","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib9","first-page":"6020","article-title":"Inhibition of Kaposi's sarcoma in vivo by fenretinide","volume":"9","author":"Ferrari","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib10","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1158\/1078-0432.CCR-04-2210","article-title":"The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide","volume":"11","author":"Ferrari","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib11","first-page":"224","article-title":"Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide","volume":"53","author":"Pienta","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1124\/mol.63.3.565","article-title":"N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death","volume":"63","author":"Tosetti","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1040-8428(01)00144-5","article-title":"Retinoids and their receptors in cancer development and chemoprevention","volume":"41","author":"Sun","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/aja.1001320404","article-title":"Sternzellen in the liver: perisinusoidal cells with special reference to storage of vitamin A","volume":"132","author":"Wake","year":"1971","journal-title":"Am J Anat"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib15","first-page":"182","article-title":"Suppression of experimental hepatic fibrosis by administration of vitamin A","volume":"52","author":"Senoo","year":"1985","journal-title":"Lab Invest"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0041-008X(78)90281-8","article-title":"Comparative subacute toxicity of all-trans- and 13-cis-retinoic acid in Swiss mice","volume":"44","author":"Hixson","year":"1978","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib17","first-page":"4606","article-title":"Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites","volume":"9","author":"Sabichi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib18","first-page":"1339","article-title":"N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat","volume":"39","author":"Moon","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib19","first-page":"3610","article-title":"Prevention of primary prostate cancer in Lobund\u2013Wistar rats by N-(4-hydroxyphenyl)retinamide","volume":"51","author":"Pollard","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(97)00454-0","article-title":"Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and beta-carotene for tobacco-nitrosamine-induced lung tumors in A\/J mice","volume":"124","author":"Conaway","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib21","first-page":"5374","article-title":"Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity","volume":"53","author":"Formelli","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib22","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1021\/bm7005592","article-title":"Fenretinide\u2013polyvinylalcohol conjugates: new systems allowing fenretinide intravenous administration","volume":"8","author":"Orienti","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2009.01.019","article-title":"Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles","volume":"373","author":"Okuda","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10717540903101655","article-title":"Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins","volume":"16","author":"Orienti","year":"2009","journal-title":"Drug Deliv"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.2910610121","article-title":"Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine","volume":"61","author":"Albini","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib26","first-page":"1151","article-title":"N-acetylcysteine inhibits endothelial cell invasion and angiogenesis","volume":"79","author":"Cai","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib27","first-page":"8171","article-title":"Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine","volume":"61","author":"Albini","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3","article-title":"Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models","volume":"67","author":"De Flora","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.it.2007.07.006","article-title":"Dendritic cell-endothelial cell cross-talk in angiogenesis","volume":"28","author":"Sozzani","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1189\/jlb.0108047","article-title":"Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo","volume":"84","author":"Villablanca","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1677\/erc.1.00938","article-title":"Clinical trials with retinoids for breast cancer chemoprevention","volume":"13","author":"Zanardi","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib33","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/jnci\/91.21.1847","article-title":"Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer","volume":"91","author":"Veronesi","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/gyno.2002.6663","article-title":"Effect of fenretinide on ovarian carcinoma occurrence","volume":"86","author":"De Palo","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1158\/1055-9965.EPI-08-0496","article-title":"Plasma retinol and prognosis of postmenopausal breast cancer patients","volume":"18","author":"Formelli","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/annonc\/mdl047","article-title":"Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer","volume":"17","author":"Veronesi","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/er.18.6.801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib38","first-page":"4722","article-title":"Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide","volume":"9","author":"Decensi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/1541-7786.MCR-05-0038","article-title":"Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary gland","volume":"3","author":"Tu","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib40","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/carcin\/bgi038","article-title":"N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells","volume":"26","author":"Simeone","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib41","first-page":"551","article-title":"Comparative teratogenicity of nine retinoids in the rat","volume":"73","author":"Turton","year":"1992","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib42","first-page":"136","article-title":"Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation","volume":"55","author":"Fontana","year":"1987","journal-title":"Exp Cell Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib43","first-page":"4472","article-title":"Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats","volume":"49","author":"Ratko","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib44","first-page":"465","article-title":"Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention","volume":"11","author":"Cope","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib45","first-page":"4614","article-title":"Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen","volume":"54","author":"Anzano","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jnci\/88.2.123","article-title":"Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid","volume":"88","author":"Anzano","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2005.02.9934","article-title":"Preliminary results on safety and activity of a randomized, double-blind, 2\u00d72 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women","volume":"24","author":"Guerrieri-Gonzaga","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib48","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1158\/1078-0432.CCR-04-0087","article-title":"A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers","volume":"10","author":"Decensi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib49","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2008.19.3797","article-title":"Randomized double-blind 2\u00d72 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women","volume":"27","author":"Decensi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib50","first-page":"2032","article-title":"Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma","volume":"9","author":"Garaventa","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib51","first-page":"1345","article-title":"Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines","volume":"4","author":"Zou","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib52","first-page":"2973","article-title":"N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium","volume":"6","author":"Kurie","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-009-9228-6","article-title":"Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer","author":"Schneider","year":"2009","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib54","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/ijc.24677","article-title":"Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals","volume":"125","author":"Tosetti","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcb.10551","article-title":"Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma","volume":"89","author":"Lovat","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib56","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/91.13.1138","article-title":"Increase of ceramide and induction of mixed apoptosis\/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines","volume":"91","author":"Maurer","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.10991","article-title":"In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma","volume":"104","author":"Raffaghello","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib58","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0889-8588(05)70256-2","article-title":"Retinoid therapy of childhood cancer","volume":"15","author":"Reynolds","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<262::AID-IJC16>3.0.CO;2-A","article-title":"N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death","volume":"81","author":"Montaldo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib60","first-page":"2230","article-title":"Fenretinide activates caspases and induces apoptosis in gliomas","volume":"5","author":"Puduvalli","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib61","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/0008-5472.CAN-04-0786","article-title":"Induction of apoptosis in primary meningioma cultures by fenretinide","volume":"65","author":"Puduvalli","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jnci\/djh268","article-title":"Fenretinide activates a distinct apoptotic pathway","volume":"96","author":"Dmitrovsky","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2407-7-236","article-title":"Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor beta dependent","volume":"7","author":"Bu","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib64","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/90.8.597","article-title":"Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide","volume":"90","author":"Sabichi","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib65","doi-asserted-by":"crossref","first-page":"45614","DOI":"10.1074\/jbc.M106559200","article-title":"Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide","volume":"276","author":"Hail","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib66","first-page":"2493","article-title":"Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms","volume":"59","author":"Sun","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib67","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1038\/sj.onc.1203024","article-title":"Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells","volume":"18","author":"Suzuki","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib68","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.cdd.4401242","article-title":"Fenretinide induces cytochrome c release, caspase 9 activation and apoptosis in the absence of mitochondrial membrane depolarisation","volume":"10","author":"Ulukaya","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/excr.2000.4988","article-title":"Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma","volume":"260","author":"Lovat","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib70","first-page":"1011","article-title":"Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids","volume":"32","author":"Cuperus","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib71","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/0008-5472.CAN-08-0031","article-title":"Involvement of Rac in fenretinide-induced apoptosis","volume":"68","author":"Kadara","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib72","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jnci\/djn076","article-title":"Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation","volume":"100","author":"Kang","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib73","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/carcin\/bgp067","article-title":"PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation","volume":"30","author":"Appierto","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib74","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-08-2150","article-title":"Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma","volume":"15","author":"Hill","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib75","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/1078-0432.CCR-08-2477","article-title":"The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response","volume":"15","author":"Pagnan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib76","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1089\/ars.2007.1819","article-title":"How transmembrane proteins sense endoplasmic reticulum stress","volume":"9","author":"Kohno","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib77","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.yexcr.2008.02.002","article-title":"The PERK\/eIF2 alpha signaling pathway of unfolded protein response is essential for N-(4-hydroxyphenyl)retinamide (4HPR)-induced cytotoxicity in cancer cells","volume":"314","author":"Lai","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib78","first-page":"4331","article-title":"Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation","volume":"60","author":"DiPietrantonio","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib79","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1158\/0008-5472.CAN-04-0377","article-title":"Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators","volume":"64","author":"Batra","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib80","doi-asserted-by":"crossref","first-page":"49531","DOI":"10.1074\/jbc.M209962200","article-title":"Ceramide signaling in fenretinide-induced endothelial cell apoptosis","volume":"277","author":"Erdreich-Epstein","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib81","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/jnci\/djh254","article-title":"Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide","volume":"96","author":"Lovat","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib82","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.leu.2402485","article-title":"N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes","volume":"16","author":"O\u2019Donnell","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib83","first-page":"5102","article-title":"N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase","volume":"61","author":"Wang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1165\/rcmb.2007-0036OC","article-title":"Fenretinide corrects newly found ceramide deficiency in cystic fibrosis","volume":"38","author":"Guilbault","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib85","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1165\/rcmb.2008-0279OC","article-title":"Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide","volume":"41","author":"Guilbault","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib86","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1038\/sj.onc.1206827","article-title":"The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family","volume":"22","author":"Boya","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib87","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1124\/mol.56.6.1271","article-title":"c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide","volume":"56","author":"Chen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib88","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.cdd.4401349","article-title":"Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells","volume":"11","author":"Appierto","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3835(03)00098-3","article-title":"Induction of GADD153 and Bak: novel molecular targets of fenretinide-induced apoptosis of neuroblastoma","volume":"197","author":"Lovat","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib90","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.cdd.4401387","article-title":"N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines","volume":"11","author":"Cuello","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib91","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1535-7163.MCT-06-0346","article-title":"Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications","volume":"6","author":"Vene","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib92","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-05-4124","article-title":"Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells","volume":"66","author":"Schroeder","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3835(97)04601-6","article-title":"Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines","volume":"113","author":"Muller","year":"1997","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib94","doi-asserted-by":"crossref","first-page":"479S","DOI":"10.1093\/jn\/130.2.479S","article-title":"Advances in the development of retinoids as chemopreventive agents","volume":"130","author":"Lippman","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib95","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/blood.V97.12.3919","article-title":"Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid","volume":"97","author":"Kini","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib96","first-page":"247","article-title":"Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic","volume":"149","author":"Lingen","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib97","first-page":"5551","article-title":"Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma","volume":"58","author":"Lingen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib98","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0959-8049(97)10082-X","article-title":"Beta Interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid","volume":"34","author":"Iurlaro","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib99","first-page":"1477","article-title":"Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis","volume":"61","author":"Pili","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ijc.1441","article-title":"Inhibition of neuroblastoma-induced angiogenesis by fenretinide","volume":"94","author":"Ribatti","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(03)00105-8","article-title":"Fenretinide as an anti-angiogenic agent in neuroblastoma","volume":"197","author":"Ribatti","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib102","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/carcin\/bgh315","article-title":"Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis","volume":"26","author":"Simile","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3835(95)90166-3","article-title":"Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids","volume":"89","author":"Majewski","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib104","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib105","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1038\/sj.onc.1206772","article-title":"Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor","volume":"22","author":"Surmacz","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib106","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib107","doi-asserted-by":"crossref","first-page":"38205","DOI":"10.1074\/jbc.M203781200","article-title":"Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells","volume":"277","author":"Fukuda","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib108","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0002-9440(10)63460-8","article-title":"Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer","volume":"163","author":"Stoeltzing","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib109","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<787::AID-IJC3>3.0.CO;2-U","article-title":"Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients","volume":"76","author":"Torrisi","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib110","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1158\/1078-0432.CCR-04-1549","article-title":"Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer","volume":"11","author":"Serrano","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib111","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/bjc.1998.358","article-title":"Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines","volume":"77","author":"Favoni","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib112","first-page":"712","article-title":"Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide","volume":"60","author":"Erdreich-Epstein","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib113","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1044-579X(02)00133-5","article-title":"Angiogenesis and apoptosis","volume":"13","author":"Folkman","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib114","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0006-2952(03)00195-3","article-title":"Reduced concentrations of serum enhance the antiproliferative activity of retinoid-related molecules and accelerate the onset of apoptosis","volume":"65","author":"Lopez-Hernandez","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature05349","article-title":"Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells","volume":"444","author":"Piccirillo","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib116","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nm904","article-title":"BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect","volume":"9","author":"Hallahan","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib117","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.emboj.7601499","article-title":"Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1","volume":"26","author":"Qiu","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib118","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1158\/0008-5472.CAN-06-2407","article-title":"Preparing the \u201csoil\u201d: the premetastatic niche","volume":"66","author":"Kaplan","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib119","first-page":"197","article-title":"Retinoids as modulators of tumor cells invasion and metastasis","volume":"2","author":"Lotan","year":"1991","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib120","first-page":"1453","article-title":"Cancer combination chemotherapy with retinoids: experimental rationale","volume":"8","author":"Bollag","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib121","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1023\/A:1010905309570","article-title":"Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression","volume":"18","author":"Shaker","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib122","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3835(91)90181-G","article-title":"The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund\u2013Wistar rats","volume":"59","author":"Pollard","year":"1991","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib123","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1248\/bpb.26.1060","article-title":"Effects on M5076-hepatic metastasis of retinoic acid and N-(4-hydroxyphenyl) retinamide, fenretinide entrapped in SG-liposomes","volume":"26","author":"Takahashi","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib124","first-page":"1429","article-title":"In vitro anti-invasive effects of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma","volume":"15","author":"Kim","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/carcin\/bgi233","article-title":"N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells","volume":"27","author":"Simeone","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(01)00697-8","article-title":"Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells","volume":"174","author":"Um","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib127","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1248\/bpb.26.1412","article-title":"Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells","volume":"26","author":"Um","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib128","first-page":"249","article-title":"Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells","volume":"25","author":"Golubkov","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib129","doi-asserted-by":"crossref","first-page":"9555","DOI":"10.1158\/0008-5472.CAN-05-1585","article-title":"N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products","volume":"65","author":"Shishodia","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib130","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1158\/0008-5472.CAN-05-3473","article-title":"Tumor inflammatory angiogenesis and its chemoprevention","volume":"65","author":"Albini","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib131","first-page":"3059","article-title":"In vitro effects of fenretinide on cell-matrix interactions","volume":"20","author":"Vaccari","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib132","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1006665616932","article-title":"Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)","volume":"17","author":"Webber","year":"1999","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib133","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<688::AID-IJC11>3.0.CO;2-6","article-title":"Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion","volume":"70","author":"Rozzo","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.007_bib134","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1096\/fj.00-0531fje","article-title":"Up-regulation of prosaposin by the retinoid HPR and its effect on ceramide production and integrin receptors","volume":"15","author":"Panigone","year":"2001","journal-title":"FASEB J"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:43:19Z","timestamp":1558755799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842809002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1040842809002212"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2009.10.007","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}